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ABSTRACT
Recurrent miscarriage is an important problem in reproductive health, which affects 1–5% of couples. The aim of this article 
is to summarize current knowledge on the genetic causes of recurrent miscarriage. It presents the most common parental 
genetic disorders (karyotype abnormalities, recessive diseases carrier status, dominant diseases and thrombophilia) con-
nected with recurrent pregnancy loss, as well as research into other possible genetic causes. This review also sets out to 
demonstrate changes in the embryonic/fetal genome that may lead to abortions, and discusses the methods used to assess 
miscarried material, together with their advantages and disadvantages.
Knowledge of the genetic background of miscarriages is important for prognosis, as well as the potential planning of 
prenatal diagnostics in subsequent pregnancies. 
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INTRODUCTION
Miscarriage is the most common complication of preg-
nancy. Although it is estimated to be responsible for ending 
10–15% of clinically diagnosed pregnancies [1], the actual 
number may be four to five times higher [2]. While the Royal 
College of Obstetricians and Gynaecologists (RCOG) regard 
recurrent miscarriages as the loss of three or more successive 
pregnancies [3, 4], the American Society for Reproductive 
Medicine defines recurrent miscarriages as at least two 
successive miscarriages [5]. The problem of recurrent mis-
carriage is an important one in reproductive health, as it is 
estimated to affect between one and five percent of couples 
[6, 7]. It may have both a genetic and environmental back-
ground. The aim of this article is to summarize the current 
knowledge on the genetic causes of recurrent miscarriage 
and discuss the role of genetic diagnostics in the determina-
tion of the reasons for the pregnancy loss.
Genetic reasons may involve changes in maternal, pa-
ternal, or fetal genetic material. Genetic tests may be per-
formed in both parents as well as in the miscarriage material 
(fetus or afterbirth).
CHANGES IN PARENTAL GENETIC MATERIAL
Changes in parental (paternal and maternal) genetic 
material that contribute to the increased risk of miscarriage 
in successive pregnancies include karyotype abnormalities, 
recessive and dominant disease carrier status, as well as 
mutations in genes responsible for coagulation and the 
metabolism of folates. The presence of karyotype abnor-
malities in one of the parents is one of the most common of 
the known causes of recurrent miscarriages. They are most 
commonly found as balanced chromosome aberrations, i.e. 
abnormalities that cause no clinical symptoms in carriers 
but possibly induce the production of abnormal reproduc-
tive cells containing abnormal amounts of genetic mate-
rial. Among couples with recurrent miscarriages, balanced 
translocations are confirmed in at least one of the partners 
in around 3% to 5% of cases [8–10]. Most commonly, these 
include reciprocal translocations, with inversions and Rob-
ertsonian translocations being less common. The status of 
a balanced chromosome aberration carrier increases the 
risk of miscarriage in subsequent pregnancies, as well as 
the risk of the child being born with an unbalanced karyo-
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type. However, with the exception of some rare cases, most 
carriers of balanced chromosome aberrations have a good 
chance of bearing healthy progeny. The risk of miscarriage 
recurring upon subsequent pregnancy or the risk of the child 
being born with a karyotype abnormality vary with regard 
to the type of chromosome aberration. Genetic diagnosis is 
performed by assessing both parental karyotypes using con-
ventional cytogenetic methods based on light microscopy. 
Recessive diseases may be induced by the presence of 
mutations responsible for single-gene recessive diseases 
in both of the parents, particularly when the parents are 
close of kin. An example of such a disease is congenital 
methemoglobinemia, as described by Kedar et al. [11]. Other 
examples include the carrier status of mutations respon-
sible for congenital arthrogryposis or Smith-Lemli-Opitz 
syndrome. Interestingly, the incidence of Smith-Lemli-Opitz 
syndrome is lower than predicted, which may be attributed 
to a lack of awareness of the wide spectrum of fetal defects 
associated with SLO syndrome among obstetricians [12]. 
If the genetic problem is an autosomal recessive disease, the 
risk of abnormality recurring in the successive pregnancy is 
high, amounting to 25%. In real clinical practice, however, 
it is very difficult to plan diagnostic screening for recessive 
disease carrier status. 
Another group of disorders is composed of autosomal 
dominant diseases which are transferred to the progeny 
with a high probability (50%). Symptoms of these diseases 
may intensify in subsequent generations (anticipation), as 
exemplified by myotonic dystrophy, a disease affecting 
mainly the muscular system, and which is associated with 
myotonia, muscle stiffness, disturbed speech and swallow-
ing. Myotonia may lead to obstetric complications includ-
ing miscarriages, preterm birth, edemas, intrauterine fetal 
demise (stillbirth), prolonged labor or intrapartum hemor-
rhages. In most cases, no such symptoms are observed in 
ancestors. Mytonic dystrophy may be suspected, for ex-
ample, when the family history includes cataract at young 
age. In such cases, an assessment of fetal development is 
particularly important, since the disease may be transferred 
with anticipation of symptoms in the progeny, particularly 
if inherited from the mother. Fetal ultrasound scans may 
show a reduced number of fetal movements and swallow-
ing disturbances, leading to polyhydramnios and club feet 
[13–15]. Although maternal symptoms may be discrete, 
mutation may lead to fetal demise or stillbirth. 
In the case of homozygotic mutations, IUFD (intrauterine 
fetal death) is associated with the presence of an autosomal 
dominant disease in both parents, one example of which is 
achondroplasia. In such cases, it is feasible to use targeted 
diagnostics in the parents, who should be offered a thor-
ough clinical examination and analysis of descent, followed 
by diagnostic molecular tests.
Diseases inherited in patterns linked to the X-chromo-
some may lead to the IUFD of male fetuses. These include 
congenital Bloch-Sulzberger disease, Goltz syndrome, Rett 
syndrome and Aicardi syndrome. As these syndromes are 
very rare, no routine diagnostic tests are currently recom-
mended for screening.
Another cause of recurrent miscarriages is congenital 
thrombophilia following damage to the maternal factor 
V gene G1691A (Leiden mutation) and prothrombin gene 
(G20210A mutation). These mutations are well studied and 
the test is part of the routine diagnostics of recurrent mis-
carriages. In the case of factor V, both the Leiden mutation 
G1691A and the T1328C mutation appear to be important 
in the pathogenesis of recurrent miscarriages, particularly 
in cases observed before the 7th week of gestation [16]. 
However, identification of the polymorphism within factor 
V gene (Leiden mutation) and prothrombin factor II gene 
may be an insufficient method of screening for congenital 
thrombophilia risk factors. Obstetric failures may also be 
caused by genetically-determined disturbances in the ac-
tivity of, inter alia, factor VII, factor XIII, or beta-fibrinogen 
[17–19]. However, no current studies report findings which 
unambiguously confirm the impact of these factors on re-
current miscarriage.
A relationship has been noted between recurrent mis-
carriage and paternal congenital thrombophilia. A six-fold 
greater risk of miscarriage was observed in pairs with pa-
ternal factor V Leiden mutation as compared to a control 
group [20]. The mechanism of this phenomenon has not 
yet been appropriately studied.
However other studies report no significant difference in 
the frequency of specific thrombophilia-responsible muta-
tions in women with a history of at least two miscarriages as 
compared to those with no pregnancy loss. This may sug-
gest that obstetric failures may be dependent on the total 
number of individual mutations rather than the presence 
of individual gene mutations [21].
The impact of mutation within the MTHFR gene, a gene 
encoding a protein involved in the metabolism of folates, on 
recurrent miscarriages is currently a matter of debate. Re-
ports suggest no relationship between hyperhomocysteine-
mia and reproductive failures. This may be due to folic acid 
supplementation, particularly during the first trimester [22].
Other studies have addressed other genetic causes for 
obstetric failure. One such disorder connected with the risk 
of recurrent miscarriage is obesity. There is evidence that 
BMI ≥ 30 kg/m² is an independent risk factor of spontane-
ous as well as recurrent abortion [7]. However, it has been 
reported that even a genetic predisposition to obesity is 
associated with a greater probability of recurrent preg-
nancy loss. Sinhalese women who experienced recurrent 
miscarriages had a significantly higher prevalence of the 
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allele variant of the single nucleotide polymorphism (SNP) 
rs9939609 in the fat and obesity associated gene (FTO) as-
sociated with obesity [23].
CHANGES IN EMBRYONIC/FETAL GENETIC 
MATERIAL
Another genomic cause of miscarriages is associated 
with the presence of fetal genetic abnormalities. These may 
include both de novo changes and changes inherited from 
one of the parents. The knowledge of whether a particular 
change is a de novo or inherited change is very important 
in genetic counseling.
It is estimated that about 50% of first-trimester preg-
nancy losses are associated with chromosome aberrations 
in the developing embryo/fetus [24, 25]. In most cases, 
these are de novo changes, which means the risk of a simi-
lar abnormality occurring during the next pregnancy is 
low [26, 27]. Kwinecka-Dmitriew et al. observed a lower 
percentage of chromosome aberrations in the material 
collected from successive miscarriage as compared to the 
first miscarriage, leading to the conclusion that other fac-
tors may be responsible for recurring miscarriage [27]. The 
largest group of abnormalities in embryonic/fetal genetic 
material consists of aberrations in the number of chromo-
somes (86%), mainly autosomal trisomies, monosomy X 
and polyploidies. The remaining group included structural 
aberrations (6%) and chromosomal mosaicism (8%) [24]. 
Fetal autosomal trisomies represent at least 50% of the 
chromosomal aberrations responsible for pregnancy loss 
[24, 25]. Trisomies may be generally observed in all auto-
somal chromosomes, although the incidence of particular 
trisomies varies. The most common trisomies are observed 
with chromosome 16 followed by chromosome 22. Also 
frequently encountered are the trisomies of chromosomes 
13, 15, 18, and 21 [25]. The risk of embryonic/fetal trisomies 
increases with maternal age [28].
ASSESSMENT OF THE MISCARRIED MATERIAL
The use of classic cytogenetic examination to assess 
fetal karyotype in the miscarried material is complicated 
by the sample being contaminated by maternal tissue and 
the associated risk of false negative results. The method 
also depends on the correct performance of cell culturing, 
which is not always possible in case of miscarried tissue [29].
Genetic analyses of the miscarried material are usually 
based on molecular biology techniques. Proper collection of 
the examined sample is important to avoid contamination 
with maternal tissue. The miscarried material must first be 
dried and rinsed of blood with physiological saline, before 
precise isolation of chorionic villi is performed [30]. If the 
fetal tissues are already well formed and visible, a fragment 
of the umbilical cord may be used for examination pur-
poses. Miscarried material may also be analyzed in paraffin 
blocks [31]; such examinations may be carried out several 
years after the block is prepared [32].
The assessment of the presence of genetic abnormalities 
within the miscarried material may be based on molecular 
diagnostic methods such as FISH, MLPA, QF-PCR, BoBs or 
comparative genomic hybridization (CGH), which allow 
not only the detection of aneuploidy in fetal tissues but 
also microdeletions and other unbalanced genomic chang-
es. Some hope is offered by novel diagnostic methods such 
as next-generation sequencing (NGS), which facilitates the 
simultaneous examination of all or selected genes, allowing 
diagnosis and then a choice for further action. An outline of 
available classic cytogenetics, molecular cytogenetics, and 
molecular biology techniques used for the examination of 
embryonic/fetal material is presented in Table 1.
SUMMARY
Recurrent miscarriages may occur due to a diverse range 
of causes. Knowledge of the genetic background of miscar-
riage is very important for prognosis, as well as to plan prena-
tal diagnostics in subsequent pregnancies. However, it is very 
difficult to make an appropriate diagnosis, particularly during 
the early stages of pregnancy. Usually, targeted genomic 
diagnostics are required following a clinical observation by 
ultrasound or pathological examination of the fetus. 
In as many as 50% of cases of recurrent miscarriage, none 
of the known causes may be determined. Therefore, new 
potential abnormalities, including genetic abnormalities that 
lead to pregnancy losses, such as a genetic predisposition to 
obesity, need to be identified, and the methods used for their 
diagnosis need to be further expanded and refined.
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